For decades, testosterone therapy was largely considered dangerous for men with a history of prostate cancer. Now, ...

June 18 (Reuters) - The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement ...

But on June 18, the U.S. Department of Health and Human Services (HHS) announced that it is requesting updates to ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

Men with low testosterone will soon have greater access to hormone replacement therapy following new changes to product labeling from the Food and Drug Administration. The Department of Health and ...

Scientist hand holding test tube with blood in laboratory. Local testosterone delivery to the prostate bed might be a better marker of post-prostatectomy outcomes than serum testosterone in some men.

The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching fluorescence of microscopy with next-generation sequencing tools. LJI ...

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...

Testosterone is the primary male sex hormone and plays an important role in maintaining muscle mass, bone health, sexual function, mood, and energy levels.

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

SAN ANTONIO — A small pilot study delivered a big message about the use of testosterone in men with advanced or metastatic prostate cancer, according to a "Best Abstract" presented at the Sexual ...